Publication: Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: A preliminary report
Issued Date
2003-09-01
Resource Type
ISSN
00359203
Other identifier(s)
2-s2.0-0242476892
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.97, No.5 (2003), 592-594
Suggested Citation
Rose McGready, Napaporn Khan Keo, Leopoldo Villegas, Nicholas J. White, Sornchai Looareesuwan, François Nosten Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: A preliminary report. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.97, No.5 (2003), 592-594. doi:10.1016/S0035-9203(03)80040-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/20885
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: A preliminary report
Abstract
Pregnant women are particularly vulnerable to malaria infections. Multidrug resistance in Plasmodium falciparum seriously compromises treatment in some endemic areas. Between April 1999 and October 2001, we treated and prospectively followed 27 Karen pregnant women with multiple recrudescent P. falciparum infections who were resistant to all other antimalarials with a triple combination of artesunate-atovaquone-proguanil. The treatment was well tolerated and we found no evidence of toxicity for the mothers and the fetus. All but 1 woman were cured (cure rate 96%, 95% CI 89-100). The triple combination of artesunate (4 mg/kg/d), atovaquone (20 mg/kg/d), and proguanil (8 mg/kg/d) may provide a much needed, albeit expensive, 3-d rescue treatment for pregnant women exposed to multidrug- resistant P. falciparum malaria.